Lv63
1830 积分 2022-07-19 加入
Advances in basic research, clinical diagnosis and treatment of prostate cancer in 2022
6天前
已完结
Phenotypic characterization of two novel cell line models of castration‐resistant prostate cancer
8天前
已完结
Fragment-Based Discovery and Structure-Led Optimization of MSC778, the First Potent, Selective, and Orally Bioavailable FEN1 Inhibitor
30天前
已完结
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
2个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
3个月前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
3个月前
已完结
Targeting DDR2 for Treating Pancreatic Cancer
3个月前
已完结
Design, synthesis, and biological evaluation of Wee1 kinase degraders
4个月前
已完结
Discovery of CRBN-dependent WEE1 Molecular Glue Degraders from a Multicomponent Combinatorial Library
4个月前
已完结
Development of clinically viable non-muscle myosin II small molecule inhibitors
4个月前
已完结
皖公网安备34019202002308
